# Golimumab (Genetical Recombination) [Golimumab Biosimilar 1] S.C. Injection 50mg Syringe "F" (ゴリムマブＢＳ皮下注５０ｍｇシリンジ「Ｆ」)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3999477G1027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3999477G1027
- **Product name (Japanese):** ゴリムマブＢＳ皮下注５０ｍｇシリンジ「Ｆ」
- **Product name (English):** Golimumab (Genetical Recombination) [Golimumab Biosimilar 1] S.C. Injection 50mg Syringe "F"
- **Active ingredient:** ゴリムマブ（遺伝子組換え）［ゴリムマブ後続１］
- **Active ingredient (INN):** Golimumab (Genetical Recombination) [Golimumab Biosimilar 1]
- **Strength / unit:** ５０ｍｇ０．５ｍＬ１筒
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 399 Other metabolic agents (n.e.c.) (他に分類されない代謝性医薬品)
- **Manufacturer:** Fuji Pharma (富士製薬工業)
- **Brand / generic:** Generic (後発医薬品)
- **NHI price (reference only):** JPY 67615 per ５０ｍｇ０．５ｍＬ１筒
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3999477G1027
- **JSON:** https://www.nifujipharma.com/api/drugs/3999477G1027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Golimumab%20(Genetical%20Recombination)%20%5BGolimumab%20Biosimilar%201%5D%20S.C.%20Injection%2050mg%20Syringe%20%22F%22%20(%E3%82%B4%E3%83%AA%E3%83%A0%E3%83%9E%E3%83%96%EF%BC%A2%EF%BC%B3%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%95%EF%BC%90%EF%BD%8D%EF%BD%87%E3%82%B7%E3%83%AA%E3%83%B3%E3%82%B8%E3%80%8C%EF%BC%A6%E3%80%8D)%20%2F%20YJ%203999477G1027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.